Page last updated: 2024-08-17

aspartic acid and ER-Negative PR-Negative HER2-Negative Breast Cancer

aspartic acid has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Chen, C; Li, Z; Liu, T; Ye, L; Yi, J	1

Other Studies

1 other study(ies) available for aspartic acid and ER-Negative PR-Negative HER2-Negative Breast Cancer

Article	Year
FN1 mediated activation of aspartate metabolism promotes the progression of triple-negative and luminal a breast cancer. Breast cancer research and treatment, 2023, Volume: 201, Issue:3 Topics: Apoptosis; Aspartic Acid; Blotting, Western; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Female; Fibronectins; Gene Expression Regulation, Neoplastic; Humans; Triple Negative Breast Neoplasms	2023

Article

Year

FN1 mediated activation of aspartate metabolism promotes the progression of triple-negative and luminal a breast cancer.

Breast cancer research and treatment, 2023, Volume: 201, Issue:3

Topics: Apoptosis; Aspartic Acid; Blotting, Western; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Female; Fibronectins; Gene Expression Regulation, Neoplastic; Humans; Triple Negative Breast Neoplasms

2023